Abstract
We have generated a mouse where the clotting factor IX (FIX) gene has been disrupted by homologous recombination. The FIX nullizygous (-/-) mouse was devoid of factor IX antigen in plasma, Consistent with the bleeding disorder, the factor IX coagulant activities for wild-type (+/+), heterozygous (+/-), and homozygous (-/-) mice were 92%, 53%, and
| Original language | English |
|---|---|
| Pages (from-to) | 11563-11566 |
| Number of pages | 4 |
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Volume | 94 |
| Issue number | 21 |
| DOIs | |
| Publication status | Published - 14 Oct 1997 |
| Externally published | Yes |
Keywords
- TRANSPLANTATION
- ADENOVIRUS
- LONG
- DOGS
- MICE
Fingerprint
Dive into the research topics of 'A factor IX-deficient mouse model for hemophilia B gene therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver